Novel anti-cancer drugs combination radio-immunotherapy strategy: new frontiers in cancer immunotherapy

3,571
Total downloads
16k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 23 Oct 2025

P3-GemOx as a novel immunochemotherapy candidate in NK/T-cell lymphoma management

Yuyang Zhang
Haiming Kou
Zhipeng Cheng
Xuan Lu
Yu Hu
Liang V. Tang

doi 10.3389/fmed.2025.1666601

442 views

ORIGINAL RESEARCH

Published on 23 Sep 2025

Cost-effectiveness analysis of lurbinectedin plus atezolizumab as first-line treatment for extensive-stage small-cell lung cancer

Yufan Huang
Zheqi Xu
Leilei Bao

doi 10.3389/fimmu.2025.1658740

1,617 views

CASE REPORT

Published on 11 Sep 2025

Long-term complete remission with immunotherapy in advanced RET fusion-positive NSCLC with brain metastases: a case report and literature review

Shuheng Shang
Meng Qin
Shuangmei Zhang

doi 10.3389/fonc.2025.1597110

1,285 views

STUDY PROTOCOL

Published on 08 Aug 2025

Total neoadjuvant chemoradiotherapy plus anti PD-1 for mid-to-low locally advanced rectal cancer: study protocol of a prospective, single arm, phase II study (STARS - RC06)

Meichen Gu
Yuchen Guo
Liang He
Xuan Sun
Tingting Liang
Zhuo Wang
Ying Li
Zheng Liu
Jingyu Wang
3 more
Quan Wang

doi 10.3389/fonc.2025.1594927

1,407 views

MINI REVIEW

Published on 04 Jul 2025

Immuno-protective impact and clinical translation of radioprotective agents in cancer radiotherapy

Yiyong Huang
Xiaolan Lv
Tao Si
Xia Meng
Xiaolin Liao
Pengfei Zhang
Zheng Peng
Zheyi Zhou
Ping Yi
Shigao Huang

doi 10.3389/fimmu.2025.1610296

1,691 views

ORIGINAL RESEARCH

Published on 23 Jun 2025

BRICS sequential therapeutic regimen as first-Line treatment for PD-L1-negative metastatic non-small cell lung cancer patients harboring EGFR/ALK wild-type status: a retrospective study

Jianxin Chen
Jian Wang
Weiqiang Fang
Yating Wu
Hang Li
Hui Xu
Yunyun Zhu
Yanran Cheng
Zongyang Yu
Yonghai Peng

doi 10.3389/fimmu.2025.1618110

1,950 views
1 citation

MINI REVIEW

Published on 13 May 2025

Ultrasound-assisted immunotherapy for malignant tumour

Xiaowen Cai
Yujie Liu
Guosheng Luo
Zhanwang Yu
Cheng Jiang
Chuanshan Xu

doi 10.3389/fimmu.2025.1547594

2,614 views
1 citation

ORIGINAL RESEARCH

Published on 08 May 2025

Combined stereotactic radiation therapy and immunotherapy for metastatic uveal melanoma

Valeria V. Nazarova
Kristina V. Orlova
Zakhra R. Magomedova
Denis S. Romanov
Raman Maskalenka
Andrey A. Yarovoy
Vera A. Yarovaya
Oxana P. Trofimova
Irina Zh. Shubina
Lev V. Demidov

doi 10.3389/fonc.2025.1567504

1,495 views
1 citation

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.3 impact factor
- 6.9 citescore

Impact

16kTopic views
12kArticle views
3,571Article downloads

View impact

Articles

P3-GemOx as a novel immunochemotherapy candidate in NK/T-cell lymphoma management

Cost-effectiveness analysis of lurbinectedin plus atezolizumab as first-line treatment for extensive-stage small-cell lung cancer

Long-term complete remission with immunotherapy in advanced RET fusion-positive NSCLC with brain metastases: a case report and literature review

Total neoadjuvant chemoradiotherapy plus anti PD-1 for mid-to-low locally advanced rectal cancer: study protocol of a prospective, single arm, phase II study (STARS - RC06)

Immuno-protective impact and clinical translation of radioprotective agents in cancer radiotherapy

BRICS sequential therapeutic regimen as first-Line treatment for PD-L1-negative metastatic non-small cell lung cancer patients harboring EGFR/ALK wild-type status: a retrospective study

Ultrasound-assisted immunotherapy for malignant tumour

Combined stereotactic radiation therapy and immunotherapy for metastatic uveal melanoma

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology

Cancer Immunity and Immunotherapy